Novel tumor targeting

AbbVie is leveraging its areas of strength to investigate therapies that are designed to target markers on cancer cells.

Novel tumor targeting...

  • Uses antigens (markers on cells) to specifically target cells that express the marker, including cancer cells, with therapeutic agents.1
  • The ideal antigen is present on cancer cells but not on normal cells.1

 

 

Why it matters...

AbbVie leverages its expertise across multiple technology platforms to identify novel antigens and approaches needed to target them.

 

References

[1] Alatrash G, Crain, A, et al. Chapter 7 – Tumor-Associated Antigens. Immune Biologic Allogeneic Hematopoeitic Stem cell Transplantation. 2019(2):107-125.